We are live on ! Find out more
RJFSA

Raymond James Financial Services Advisors Portfolio holdings

AUM $75.1B
1-Year Est. Return 31.89%
This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
+31.89%
3 Year Est. Return
+38.17%
5 Year Est. Return
+106.56%
10 Year Est. Return
+236.84%
AUM
$67.3B
AUM Growth
+$5.8B
Cap. Flow
+$761M
Cap. Flow %
1.13%
Top 10 Hldgs %
16.93%
Holding
3,547
New
263
Increased
1,557
Reduced
1,465
Closed
162
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNN icon
3326
Denison Mines
DNN
$2.98B
$21K ﹤0.01%
+10,776
New +$20.4K
REFR icon
3327
Research Frontiers
REFR
$16.8M
$20.7K ﹤0.01%
15,935
BNGO icon
3328
Bionano Genomics
BNGO
$13.7M
$20.5K ﹤0.01%
+308
New +$23K
ATOS icon
3329
Atossa Therapeutics
ATOS
$23.6M
$19.5K ﹤0.01%
721
DNMR
3330
DELISTED
Danimer Scientific, Inc.
DNMR
$19.2K ﹤0.01%
441
BBGI icon
3331
Beasley Broadcasting Group
BBGI
$38.7M
$19.2K ﹤0.01%
1,233
PFIE
3332
DELISTED
Profire Energy, Inc
PFIE
$19K ﹤0.01%
10,288
XOM icon
3333
PUT
ExxonMobil
XOM
$657B
$19K ﹤0.01%
200
BHIL
3334
DELISTED
Benson Hill, Inc.
BHIL
$17K ﹤0.01%
2,429
+143
+6% +$979
AMWL icon
3335
American Well
AMWL
$214M
$15.2K ﹤0.01%
939
INVZ icon
3336
Innoviz Technologies
INVZ
$116M
$14.3K ﹤0.01%
+10,606
New +$17.8K
KSCP icon
3337
Knightscope
KSCP
$30.2M
$13.7K ﹤0.01%
548
+347
+173% +$9.09K
VGZ icon
3338
Vista Gold
VGZ
$336M
$13.1K ﹤0.01%
23,250
-1,616
-6% -$663
OESX icon
3339
Orion Energy Systems
OESX
$83.8M
$12.9K ﹤0.01%
1,480
BMRA icon
3340
Biomerica
BMRA
$4.85M
$12.1K ﹤0.01%
1,813
EVA
3341
DELISTED
Enviva Inc.
EVA
$11.5K ﹤0.01%
26,041
-12,632
-33% -$6.63K
LILM
3342
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$11.3K ﹤0.01%
11,812
-2,817
-19% -$2.62K
TSLA icon
3343
PUT
Tesla
TSLA
$1.29T
$10K ﹤0.01%
+100
New +$19.5K
CTXR icon
3344
Citius Pharmaceuticals
CTXR
$20.5M
$9.96K ﹤0.01%
444
DARE icon
3345
Dare Bioscience
DARE
$21.7M
$9.8K ﹤0.01%
1,667
-632
-27% -$3.1K
SKGRW
3346
DELISTED
SK Growth Opportunities Corporation Warrant
SKGRW
$9.5K ﹤0.01%
+20,216
New +$6.18K
SGMO
3347
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$8.95K ﹤0.01%
13,349
-2,890
-18% -$2.1K
VLD
3348
DELISTED
Velo3D, Inc.
VLD
$8.68K ﹤0.01%
+544
New +$6.14K
AGEN
3349
Agenus
AGEN
$316M
$8.21K ﹤0.01%
708
-601
-46% -$7.97K
VAXX
3350
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$8.01K ﹤0.01%
11,170
-7,325
-40% -$5.31K

Similar funds

Raymond James Financial Services Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Raymond James Financial Services Advisors held 3,547 positions worth $67.3B, up 9.4% from $61.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Raymond James Financial Services Advisors's Q1 2024 filing shows 263 new, 1,557 increased, 1,465 reduced and 162 closed positions. Its largest new stake was JPMorgan Equity Focus ETF: 475,290 shares worth $28.4M. The largest sale was WisdomTree Trust WisdomTree US Quality Dividend Growth Fund, an estimated $73M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James Financial Services Advisors's largest Q1 2024 buy was JPMorgan Equity Focus ETF: 475,290 shares worth $28.4M.
  • Raymond James Financial Services Advisors added most to DexCom in Q1 2024, an estimated $53.5M increase.
  • Raymond James Financial Services Advisors's biggest Q1 2024 reduction was WisdomTree Trust WisdomTree US Quality Dividend Growth Fund, cutting an estimated $73M.
  • Raymond James Financial Services Advisors fully exited Invesco Equal Weight 0-30 Year Treasury ETF in Q1 2024, selling an estimated $16.8M.
  • Raymond James Financial Services Advisors's ten largest holdings make up 17% of its $67.3B portfolio in Q1 2024.
  • Raymond James Financial Services Advisors opened 263 new positions and closed 162 in Q1 2024.
  • Raymond James Financial Services Advisors's portfolio value rose 9.4% quarter-over-quarter to $67.3B.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2024, filed 22 Apr 2024.